Waldenström's macroglobulinemia other diagnostic studies: Difference between revisions
No edit summary |
No edit summary |
||
| Line 13: | Line 13: | ||
'''References''' | |||
{{reflist|2}} | {{reflist|2}} | ||
Revision as of 19:36, 13 November 2015
|
Waldenström's macroglobulinemia Microchapters |
|
Differentiating Waldenström's macroglobulinemia from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Waldenström's macroglobulinemia other diagnostic studies On the Web |
|
American Roentgen Ray Society Images of Waldenström's macroglobulinemia other diagnostic studies |
|
FDA on Waldenström's macroglobulinemia other diagnostic studies |
|
CDC on Waldenström's macroglobulinemia other diagnostic studies |
|
Waldenström's macroglobulinemia other diagnostic studies in the news |
|
Blogs on Waldenström's macroglobulinemia other diagnostic studies |
|
Directions to Hospitals Treating Waldenström's macroglobulinemia |
|
Risk calculators and risk factors for Waldenström's macroglobulinemia other diagnostic studies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Mirdula Sharma, MBBS [2]
Overview
Patients with Waldenström's macroglobulinemia should have nerve conduction study and antimyelin associated glycoprotein serology done.[1]
Nerve conduction study
- Patients with Waldenström's macroglobulinemia should have nerve conduction study done.[1]
Serology
- Waldenström's macroglobulinemia should have antimyelin associated glycoprotein serology done.[1]
References
- ↑ 1.0 1.1 1.2 Waldenström's macroglobulinemia. UpToDate (2015)http://www.uptodate.com/contents/epidemiology-pathogenesis-clinical-manifestations-and-diagnosis-of-waldenstrom-macroglobulinemia?source=machineLearning&search=Waldenström%27s+macroglobulinemia&selectedTitle=1%7E80§ionRank=3&anchor=H29#H18 Accessed on November 11, 2015